America December 15, 2025
Sobi to Acquire Arthrosi Therapeutics in $1.5B Gout Drug Bet
Swedish biopharmaceutical company Swedish Orphan Biovitrum AB said Monday it has struck a deal to buy Arthrosi Therapeutics Inc., a…
America December 15, 2025
Swedish biopharmaceutical company Swedish Orphan Biovitrum AB said Monday it has struck a deal to buy Arthrosi Therapeutics Inc., a…
By Rihem Akkouche
America November 14, 2025
A high-stakes bellwether trial that could shape the trajectory of thousands of talc-cancer claims nationwide erupted Thursday with accusations that…
By Rihem Akkouche
America November 14, 2025
In a dramatic move that reshapes the biopharma landscape, Day One Biopharmaceuticals revealed Thursday that it will acquire Mersana Therapeutics…
By Rihem Akkouche
America October 27, 2025
In a bold move against a backdrop of federal uncertainty, MapLight Therapeutics has gone public, raising $251 million in its…
By Rihem Akkouche
America September 25, 2025
Wall Street’s appetite for risk lit up again Thursday as Drugs Made In America Acquisition II stormed onto the Nasdaq,…
By Rihem Akkouche
America September 15, 2025
In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…
By Rihem Akkouche
America March 25, 2025
Merck & Co. Inc. is making a high-stakes move in the cardiovascular drug market, announcing on Tuesday an exclusive licensing…
By Rihem Akkouche
America March 21, 2025
In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment…
By Rihem Akkouche
America May 25, 2024
Fox Rothschild LLP is bringing on a surgeon-turned-attorney with experience in patent advising within biotech, chemicals, and pharmaceuticals to its…
By Rochdi Rais
America March 25, 2024
In a groundbreaking move, Novo Nordisk A/S, the Danish pharmaceutical juggernaut, has set its sights on Cardior Pharmaceuticals of Germany,…
By Rihem Akkouche